🎄✨ Thank You from Pharmidex! ✨🎄
December 19, 2024
As the year comes to a close, everyone at
Pharmidex would like to take this opportunity to express our heartfelt gratitude for your trust, support, and partnership.
We wish you a healthy, happy, and prosperous new year ahead! 🌟
In keeping with our tradition, we are proud to support charities that make a meaningful difference in people's lives. Here's to another year of collaboration and innovation together!
The body content of your post goes here. To edit this text, click on it and delete this default text and start typing your own or paste your own from a different source.
Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) and Janette Dalay Robertson will attend the “Recent Clinical Candidates and SMR Award Meeting” this Thursday, 4 December 2025. If you’re attending, we’d be happy to connect!
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) , and our Dr. Ian Knowles , will attend Genesis 2025 this Wednesday, December 3rd, hosted by One Nucleus . They look forward to meeting fellow attendees, exploring new collaborations, and building partnerships with companies and academic groups to advance drug discovery and development. See you at Genesis 2025!
